Domperidone as an anti-emetic; summary of research reports.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000932:Antiemetics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006259:Craniocerebral Trauma / Q000150:complications; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D004412:Dysmenorrhea / Q000150:complications; D004945:Esophagoscopy / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications; D009325:Nausea / Q000188:drug therapy / Q000209:etiology; D010880:Piperidines / Q000627:therapeutic use*; D011292:Premedication; D011878:Radiotherapy / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects; D014839:Vomiting / Q000188:drug therapy / Q000209:etiology
D000893:Anti-Inflammatory Agents; D000932:Antiemetics; D001562:Benzimidazoles; D010880:Piperidines; D004295:Dihydroxyphenylalanine